Estrogen-mediated suppression of the gene encoding protein tyrosine phosphatase PTPRO in human breast cancer: Mechanism and role in tamoxifen sensitivity

Molecular Endocrinology

Volumn 23, Issue 2, 2009, Pages 176-187

  Ramaswamy, Bhuvaneswari ^a,b   Majumder, Sarmila ^a,b   Roy, Satavisha ^b   Ghoshal, Kalpana ^a,b   Kutay, Huban ^b   Datta, Jharna ^b   Younes, Mamoun ^c   Shapiro, Charles L ^a,b   Motiwala, Tasneem ^b,d   Jacob, Samson T ^a,b,d  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZACITIDINE; ESTRADIOL; ESTROGEN; PROTEIN C FOS; PROTEIN C JUN; PROTEIN TYROSINE PHOSPHATASE; TAMOXIFEN;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL; CARCINOGENESIS; CONTROLLED STUDY; DEMETHYLATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METHYLATION;

ANTINEOPLASTIC AGENTS, HORMONAL; BASE SEQUENCE; BREAST NEOPLASMS; CELL LINE, TUMOR; DNA METHYLATION; ESTRADIOL; ESTROGEN RECEPTOR BETA; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS, GENETIC; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 3; TAMOXIFEN; TRANSCRIPTION FACTOR AP-1;

EID: 58849107892     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2008-0211     Document Type: Article

References (50)

1. Russo J, Hu YF, Yang X, Russo IH 2000 Developmental, cellular, and molecular basis of human breast cancer. J Natl Cancer Inst Monogr:17-37
2. Peppercorn J, Perou CM, Carey LA 2008 Molecular subtypes in breast cancer evaluation and management: divide and conquer. Cancer Invest 26:1-10
3. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D 2000 Molecular portraits of human breast tumours. Nature 406:747-752
4. Henderson BE, Feigelson HS 2000 Hormonal carcinogenesis. Carcinogenesis 21:427-433
5. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA 1996 Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93:5925-5930
6. Kuiper GG, Gustafsson JA 1997 The novel estrogen receptor-β subtype: potential role in the cell- and promoter-specific actions of estrogens and antiestrogens. FEBS Lett 410:87-90
7. Dotzlaw H, Leygue E, Watson PH, Murphy LC 1999 Estrogen receptor-β messenger RNA expression in human breast tumor biopsies: relationship to steroid receptor status and regulation by progestins. Cancer Res 59:529-532
8. Iwao K, Miyoshi Y, Egawa C, Ikeda N, Noguchi S 2000 Quantitative analysis of estrogen receptor-β mRNA and its variants in human breast cancers. Int J Cancer 88:733-736
9. Roger P, Sahla ME, Makela S, Gustafsson JA, Baldet P, Rochefort H 2001 Decreased expression of estrogen receptor β protein in proliferative preinvasive mammary tumors. Cancer Res 61:2537-2541
10. Katzenellenbogen BS, Frasor J 2004 Therapeutic targeting in the estrogen receptor hormonal pathway. Semin Oncol 31:28-38
11. Mosselman S, Polman J, Dijkema R 1996 ERj : identification and characterization of a novel human estrogen receptor. FEBS Lett 392:49-53
12. Paech K, Webb P, Kuiper GG, Nilsson S, Gustafsson J, Kushner PJ, Scanlan TS 1997 Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites. Science 277:1508-1510
13. Forster C, Makela S, Warri A, Kietz S, Becker D, Hultenby K, Warner M, Gustafsson JA 2002 Involvement of estrogen receptor β in terminal differentiation of mammary gland epithelium. Proc Natl Acad Sci USA 99:15578-15583
14. NicholsonRI, HutchesonIR, JonesHE,HiscoxSE,GilesM,TaylorKM,Gee JM 2007 Growth factor signalling in endocrine and anti-growth factor resistant breast cancer. Rev Endocr Metab Disord 8:241-253
15. Hunter T2000 Signaling-2000 and beyond. Cell 100:113-127
16. Giltnane JM, Ryden L, Cregger M, Bendahl PO, Jirstrom K, Rimm DL 2007 Quantitative measurement of epidermal growth factor receptor is a negative predictive factor for tamoxifen response in hormone receptor positive premenopausal breast cancer. J Clin Oncol 25:3007-3014
17. Liu B, Ordonez-Ercan D, Fan Z, Edgerton SM, Yang X, Thor AD 2007 Downregulation of erbB3 abrogates erbB2-mediated tamoxifen resistance in breast cancer cells. Int J Cancer 120:1874-1882
18. Alonso A, Sasin J, Bottini N, Friedberg I, Osterman A, Godzik A, Hunter T, Dixon J, Mustelin T 2004 Protein tyrosine phosphatases in the human genome. Cell 117:699-711
19. Jacob ST, Motiwala T 2005 Epigenetic regulation of protein tyrosine phosphatases: potential molecular targets for cancer therapy. Cancer Gene Ther 12:665-672
20. Motiwala T, Ghoshal K, Das A, Majumder S, Weichenhan D, Wu YZ, Holman K, James SJ, Jacob ST, Plass C 2003 Suppression of the protein tyrosine phosphatase receptor type O gene (PTPRO) by methylation in hepatocellular carcinomas. Oncogene 22:6319-6331
21. Motiwala T, Kutay H, Ghoshal K, Bai S, Seimiya H, Tsuruo T, Suster S, Morrison C, Jacob ST 2004 Protein tyrosine phosphatase receptor-type O (PTPRO) exhibits characteristics of a candidate tumor suppressor in human lung cancer. Proc Natl Acad Sci USA 101:13844-13849
22. Motiwala T, Majumder S, Kutay H, SmithDS, Neuberg DS, Lucas DM, Byrd JC, Grever M, Jacob ST 2007 Methylation and silencing of protein tyrosine phosphatase receptor type O in chronic lymphocytic leukemia. Clin Cancer Res 13:3174-3181
23. Motiwala T, Jacob ST 2006 Role of protein tyrosine phosphatases in cancer. Prog Nucleic Acid Res Mol Biol 81:297-329
24. Ehrich M, Nelson MR, Stanssens P, Zabeau M, Liloglou T, Xinarianos G, Cantor CR, Field JK, van den Boom D 2005 Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. Proc Natl Acad Sci USA 102:15785-15790
25. Cheskis BJ, Greger JG, Nagpal S, Freedman LP 2007 Signaling by estrogens. JCell Physiol 213:610-617
26. Tang S, Zhang Z, Tan SL, Ta ng MH, Kumar AP, Ramadoss SK, Bajic VB 2007 KBERG: Knowledge Base for estrogen responsive genes. Nucleic Acids Res 35:D732-D736
27. BerthoisY,Katzenellenbogen JA,Katzenellenbogen BS 1986 Phenolredin tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc Natl Acad Sci USA 83:2496-2500
28. Seimiya H, Sawabe T, Inazawa J, Tsuruo T 1995 Cloning, expression and chromosomal localization of a novel gene for protein tyrosine phosphatase (PTP-U2) induced by various differentiation-inducing agents. Oncogene 10:1731-1738
29. Hess J, Angel P, Schorpp-Kistner M 2004 AP-1 subunits: quarrel and harmony among siblings. J Cell Sci 117:5965-5973
30. Freiss G, Vignon F 1994 Antiestrogens increase protein tyrosine phosphatase activity in human breast cancer cells. Mol Endocrinol 8:1389-1396
31. Tsai MJ, O'Malley BW 1994 Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 63:451-486
32. Brzozowski AM, Pike AC, Dauter Z, Hubbard RE, Bonn T, Engstrom O, Ohman L, Greene GL, Gustafsson JA, Carlquist M 1997 Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389:753-758
33. Levenson AS, Catherino WH, Jordan VC 1997 Estrogenic activity is increased for an antiestrogen by a natural mutation of the estrogen receptor. J Steroid Biochem Mol Biol 60:261-268
34. Matthews J, Wihlen B, Tujague M, Wan J, Strom A, Gustafsson JA 2006 Estrogen receptor (ER) β modulates ERa-mediated transcriptional activation by altering the recruitment of c-Fos and c-Jun to estrogen-responsive promoters. Mol Endocrinol 20:534-543
35. Leu YW, Yan PS, Fan M, Jin VX, Liu JC, Curran EM, Welshons WV, Wei SH, Davuluri RV, Plass C, Nephew KP,Huang TH 2004 Loss of estrogen receptor signaling triggers epigenetic silencing of downstream targets in breast cancer. Cancer Res 64:8184-8192
36. Yang T, Zhang JS, Massa SM, Han X, Longo FM 1999 Leukocyte common antigen-related tyrosine phosphatase receptor: increased expression and neuronal-type splicing in breast cancer cells and tissue. Mol Carcinog 25:139-149
37. Ardini E, Agresti R, Tagliabue E, Greco M, Aiello P, Yang LT, Menard S, Sap J 2000 Expression of protein tyrosine phosphatase α (RPTPα) in human breast cancer correlates with low tumor grade, and inhibits tumor cell growth in vitro and in vivo. Oncogene 19:4979 -4987
38. Wiener JR, Kerns BJ, Harvey EL, Conaway MR, Iglehart JD, Berchuck A, Bast Jr RC 1994 Overexpression of the protein tyrosine phosphatase PTP 1B in human breast cancer: association with p185c-erbB-2 protein expression. J Natl Cancer Inst 86:372-378
39. Zhai YF, Beittenmiller H, Wang B, Gould MN, Oakley C, Esselman WJ, Welsch CW 1993 Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene. Cancer Res 53:2272-2278
40. Yip SS, Crew AJ, Gee JM, Hui R, Blamey RW, Robertson JF, Nicholson RI, Sutherland RL, Daly RJ 2000 Up-regulation of the protein tyrosine phosphatase SHP-1 in human breast cancer and correlation with GRB2 expression. Int J Cancer 88:363-368
41. Liu S, Sugimoto Y, Sorio C, Tecchio C, Lin YC 2004 Function analysis of estrogenically regulated protein tyrosine phosphatase γ (PTPγ) in human breast cancer cell line MCF-7. Oncogene 23:1256-1262
42. Zheng J, Kulp SK, Zhang Y, Sugimoto Y, Dayton MA, Govindan MV, Brueggemeier RW, Lin YC 2000 17β -Estradiol-regulated expression of protein tyrosine phosphatase γ gene in cultured human normal breast and breast cancer cells. Anticancer Res 20:11-19
43. Ghoshal K, Majumder S, Li Z, Dong X, Jacob ST 2000 Suppression of metallothionein gene expression in a rat hepatoma because of promoter-specific DNA methylation. JBiol Chem 275:539-547
44. Majumder S, Ghoshal K, Li Z, Jacob ST 1999 Hypermethylation of metallothionein-I promoter and suppression of its induction in cell lines overexpressing the large subunit of Ku protein. J Biol Chem 274:28584-28589
45. Chomczynski P, Sacchi N 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
46. Datta J, Majumder S, Kutay H, Motiwala T, Frankel W, Costa R, Cha HC, MacDougald OA, Jacob ST, Ghoshal K 2007 Metallothionein expression is suppressed in primary human hepatocellular carcinomas and is mediated through inactivation of CCAAT/enhancer binding protein α by phospha-tidylinositol 3-kinase signaling cascade. Cancer Res 67:2736-2746
47. Weitsman GE, Skliris G, Ung K, Peng B, Younes M, Watson PH,Murphy LC 2006 Assessment of multiple different estrogen receptor-β antibodies for their ability to immunoprecipitate under chromatin immunoprecipitation conditions. Breast Cancer Res Treat 100:23-31
48. Ghoshal K, Datta J, Majumder S, Bai S, Dong X, Parthun M, Jacob ST 2002 Inhibitors of histone deacetylase and DNA methyltransferase synergistically activate the methylated metallothionein I promoter by activating the transcription factor MTF-1 and forming an open chromatin structure. Mol Cell Biol 22:8302-8319
49. Ghoshal K, Majumder S, Datta J, Motiwala T, Bai S, Sharma SM, Frankel W, Jacob ST 2004 Role of human ribosomal RNA (rRNA) promoter methylation and of methyl-CpG-binding protein MBD2 in the suppression of rRNA gene expression. J Biol Chem 279:6783-6793
50. Motiwala T, Majumder S, Ghoshal K, Kutay H, Datta J, Roy S, Lucas DM, Jacob ST 2008 PTPROt inactivates the oncogenic fusion protein BCR/ABL and suppresses transformation of K562 cells. J Biol Chem 284:455-464